Stanford University
Showing 901-1,000 of 2,473 Results
-
Karen G. Hirsch, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01). The research team works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury, and with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.
Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death, organ donation, and neuroethics. She is the Co-PI of BCI-DEF (Brain Computer Interfaces and Disability: Developing an Inclusive Ethical Framework, NIMH 1R01MH130518-01) which is a BRAIN Initiative funded study that is qualitatively evaluating end user perspectives about the benefits, risks, and ethical challenges of Brain Computer Interfaces for patients with acute stroke or traumatic brain injury.
Dr. Hirsch is broadly interested in improving neurologic outcomes after acute severe brain injury, identifying early phenotypes to guide precision medicine in neurocritical care, and exploring ethical issues in neurocritical care and novel neurotechnology. Dr. Hirsch greatly appreciates the importance of team science and collaboration. -
Daniel Ho
William Benjamin Scott & Luna M. Scott Professor of Law, Professor of Political Science, Senior Fellow at the Stanford Institute for Economic Policy Research, at the Stanford Institute for HAI and Professor, by courtesy, of Computer Science
BioDaniel E. Ho is the William Benjamin Scott and Luna M. Scott Professor of Law, Professor of Political Science, Professor of Computer Science (by courtesy), Senior Fellow at Stanford's Institute for Human-Centered Artificial Intelligence, and Senior Fellow at the Stanford Institute for Economic Policy Research at Stanford University. He is a Faculty Fellow at the Center for Advanced Study in the Behavioral Sciences and is Director of the Regulation, Evaluation, and Governance Lab (RegLab). Ho serves on the National Artificial Intelligence Advisory Commission (NAIAC), advising the White House on artificial intelligence, as Senior Advisor on Responsible AI at the U.S. Department of Labor, and as a Public Member of the Administrative Conference of the United States (ACUS). He received his J.D. from Yale Law School and Ph.D. from Harvard University and clerked for Judge Stephen F. Williams on the U.S. Court of Appeals, District of Columbia Circuit.
-
Keith Hodgson
David Mulvane Ehrsam and Edward Curtis Franklin Professor of Chemistry and Professor of Photon Science
BioCombining inorganic, biophysical and structural chemistry, Professor Keith Hodgson investigates how structure at molecular and macromolecular levels relates to function. Studies in the Hodgson lab have pioneered the use of synchrotron x-radiation to probe the electronic and structural environment of biomolecules. Recent efforts focus on the applications of x-ray diffraction, scattering and absorption spectroscopy to examine metalloproteins that are important in Earth’s biosphere, such as those that convert nitrogen to ammonia or methane to methanol.
Keith O. Hodgson was born in Virginia in 1947. He studied chemistry at the University of Virginia (B.S. 1969) and University of California, Berkeley (Ph.D. 1972), with a postdoctoral year at the ETH in Zurich. He joined the Stanford Chemistry Department faculty in 1973, starting up a program of fundamental research into the use of x-rays to study chemical and biological structure that made use of the unique capabilities of the Stanford Synchrotron Radiation Lightsource (SSRL). His lab carried out pioneering x-ray absorption and x-ray crystallographic studies of proteins, laying the foundation for a new field now in broad use worldwide. In the early eighties, he began development of one of the world's first synchrotron-based structural molecular biology research and user programs, centered at SSRL. He served as SSRL Director from 1998 to 2005, and SLAC National Accelerator Laboratory (SLAC) Deputy Director (2005-2007) and Associate Laboratory Director for Photon Science (2007-2011).
Today the Hodgson research group investigates how molecular structure at different organizational levels relates to biological and chemical function, using a variety of x-ray absorption, diffraction and scattering techniques. Typical of these molecular structural studies are investigations of metal ions as active sites of biomolecules. His research group develops and utilizes techniques such as x-ray absorption and emission spectroscopy (XAS and XES) to study the electronic and metrical details of a given metal ion in the biomolecule under a variety of natural conditions.
A major area of focus over many years, the active site of the enzyme nitrogenase is responsible for conversion of atmospheric di-nitrogen to ammonia. Using XAS studies at the S, Fe and Mo edge, the Hodgson group has worked to understand the electronic structure as a function of redox in this cluster. They have developed new methods to study long distances in the cluster within and outside the protein. Studies are ongoing to learn how this cluster functions during catalysis and interacts with substrates and inhibitors. Other components of the protein are also under active study.
Additional projects include the study of iron in dioxygen activation and oxidation within the binuclear iron-containing enzyme methane monooxygenase and in cytochrome oxidase. Lab members are also investigating the role of copper in electron transport and in dioxygen activation. Other studies include the electronic structure of iron-sulfur clusters in models and enzymes.
The research group is also focusing on using the next generation of x-ray light sources, the free electron laser. Such a light source, called the LCLS, is also located at SLAC. They are also developing new approaches using x-ray free electron laser radiation to image noncrystalline biomolecules and study chemical reactivity on ultrafast time scales. -
Andrew R. Hoffman
Professor of Medicine (Endocrinology), Emeritus
Current Research and Scholarly InterestsMechanism of genomic imprinting of insulin like growth factor-2 and other genes.Long range chromatin interactions Role of histone modifications and DNA methylation in gene expression.
-
Lawrence "Rusty" Hofmann, MD
Professor of Radiology (Interventional Radiology)
On Partial Leave from 2026-07-26 To 2026-12-31BioDr. Lawrence “Rusty” Hofmann is an actively practicing physician and Professor of Interventional Radiology at Stanford School of Medicine, as well as the Chief of Industry Partnerships for Stanford Healthcare, Medical Director of Cardiac and Interventional Services, and the Medical Director of Digital Health at Stanford Medicine. He served as Chief of Interventional Radiology at Stanford for nearly two decades. He is the Co-Founder of Grand Rounds, Inc, rebranded as Included Health. He has devoted his career to providing state-of-the-art care to patients at either Johns Hopkins, where he practiced for 10 years, or Stanford, where he practiced for 15 years. He has published over 100 scientific articles on minimally invasive treatment of blood clots (DVT) and cancer. He has always had in interest in innovation. He holds 2 patents, has worked as a consultant for numerous medical device companies, both start-ups and large companies and is currently the Global-Principal Investigator for the first clinical trial testing a venous stent. He has invented and brought a number of devices from napkin stage to world-wide use. He has active digital health research projects at the intersection of artificial intelligence and clinical care, including telemedicine and deep venous thrombosis.
-
David Holloway
Raymond A. Spruance Professor of International History, Professor of Political Science and Senior Fellow at the Freeman Spogli Institute for International Studies, Emeritus
Current Research and Scholarly Interestscivil wars; history of nuclear weapons
-
Susan Holmes
Professor of Statistics, Emerita
Current Research and Scholarly InterestsOur lab has been developing tools for the analyses of complex data structures, extending work on multivariate data to structured multitable table that include graphs, networks and trees as well as categorical and continuous measurements.
We created and support the Bioconductor package phyloseq for the analyses of microbial ecology data from the microbiome. We have specialized in developing interactive graphical visualization tools for doing reproducible research in biology. -
Mark Holodniy
Professor of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsMy research program is currently focused in three areas: 1) Translational research (viral evolution and antiviral resistance prevalence and development), 2) Clinical trials (diagnostic assay/medical device, antimicrobials and immunomodulators), and 3) Health services research focusing on public health, infectious diseases and clinical outcomes.
-
David S. Hong
Associate Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
On Partial Leave from 2026-08-01 To 2026-10-31Current Research and Scholarly InterestsDr. Hong is a child and adolescent psychiatrist and clinician-scientist. His responsibilities span clinical care, teaching/mentorship, and research, with a unifying theme of advancing a developmental cognitive framework as applied to psychiatric conditions. Using this core premise, he work encompasses multiple domains: specialized clinical care, fellowship training, research mentorship, and elaborating the role of sex-specific determinants of development, one of the greatest contributors to individual developmental variation.
His lab investigates genetic and hormonal influences underlying sex differences in child psychiatric conditions. Sex has emerged as a critical variable driving differences in the phenomenology, course, and treatment of many mental health disorders. Unfortunately, an understanding of the biological mechanisms driving these effects are limited. By applying innovative neuroimaging and multiomic approaches, Dr. Hong seeks to provide a deeper understanding of the connection between sex-specific effects and complex psychiatric diseases. To do so, research in the Hong Lab focuses on the role of genes on the X and Y chromosomes, as well as circulating sex hormones on brain development, cognition, and behavior. The lab broadly aims to elucidate the changing nature of these mechanisms across various stages of development.
Another area of focus is the implementation of clinical informatics in child psychiatry and the development of digital mental health tools. As co-Director of the Mental Health Technology and Innovation Hub, Dr. Hong is helping to develop clinical and research infrastructure within the Department of Psychiatry and Behavioral Sciences to advance development of mobile mental health resources that will improve efficacy and access to mental health care. -
Guosong Hong
Assistant Professor of Materials Science and Engineering
Current Research and Scholarly InterestsGuosong Hong is a materials scientist developing materials-enabled photonic technologies for noninvasive imaging and neuromodulation in living systems. His research pioneers in vivo optical transparency and deep-tissue light-matter interactions, guided by fundamental principles in physics and chemistry, to enable new ways to visualize, modulate, and ultimately treat biological function in health and disease.
-
Yusuke Hori, MD
Instructor, Neurosurgery
BioDr. Hori received his MD from Sapporo Medical University, Japan, and during that time he served as a Medical Student Research Fellow in the Department of Pharmacology. He explored the functional role of the SIRT1 gene, a longevity-associated gene, and its association with various conditions such as muscular dystrophy. He also completed a Visiting Student Research Fellowship at the Health Sciences University of Hokkaido and participated in Human Genetics projects focusing on an association between the 27-bp deletion and 538G>A mutation in the ABCC11 Gene.
After graduating from medical school, Dr. Hori completed a neurosurgery residency at National Hospital Organization Okayama Medical Center in Japan. Subsequently, he completed a Stereotactic and Functional Neurosurgery Fellowship and then a Neurosurgical Oncology and Radiosurgery Fellowship at The Cleveland Clinic. He also completed an International Neurosurgery Fellowship at Boston Children's Hospital, Harvard Medical School. In 2022, he moved to Stanford University as a postdoctoral fellow, and under the supervision of Dr. Anca Pasca, he participated in brain organoid research focusing on hypoxic brain injuries.
Since July 2023, Dr. Hori has been working as a Clinical Instructor (Neurosurgical Oncology and Radiosurgery) in the Department of Neurosurgery at Stanford under the supervision of Dr. Steven D. Chang. His clinical interests include malignant brain and spine tumors in both adult and pediatric patients. His clinical research focuses on the application of minimally invasive treatments such as laser interstitial thermal therapy, focused ultrasound, and radiosurgery to treat various neurosurgical conditions. His current lab research aims to develop an organoid model for radiation-induced brain injuries and a high-throughput screening platform to identify novel therapeutic compounds, for which he received a Clinician Educator Grant from Stanford University Maternal and Child Health Research Institute. Outside of medicine, he enjoys playing music including guitar and drums. -
Felix Horns
Assistant Professor of Genetics
BioFelix Horns is an Assistant Professor of Genetics at Stanford University and a Core Investigator at Arc Institute. The Horns group works at the interface of synthetic biology and genomics to develop and apply technologies for monitoring and manipulating cells, with particular focus on the immune system and the brain.
Felix earned his B.A. in Biology from Amherst College and his Ph.D. in Biophysics working with Dr. Stephen Quake at Stanford, where he developed and used single-cell genomics, high-throughput sequencing, and computational analysis approaches to understand the origins of human antibody diversity and to discover principles of how brain circuits assemble during development. He then joined Dr. Michael Elowitz's lab at the California Institute of Technology where he combined synthetic biology and genomics approaches to develop RNA packaging, secretion, and delivery systems, which open new avenues for understanding and controlling cellular behaviors. -
Mark Horowitz
Fortinet Founders Chair of the Department of Electrical Engineering, Yahoo! Founders Professor in the School of Engineering and Professor of Computer Science
BioProfessor Horowitz initially focused on designing high-performance digital systems by combining work in computer-aided design tools, circuit design, and system architecture. During this time, he built a number of early RISC microprocessors, and contributed to the design of early distributed shared memory multiprocessors. In 1990, Dr. Horowitz took leave from Stanford to help start Rambus Inc., a company designing high-bandwidth memory interface technology. After returning in 1991, his research group pioneered many innovations in high-speed link design, and many of today’s high speed link designs are designed by his former students or colleagues from Rambus.
In the 2000s he started a long collaboration with Prof. Levoy on computational photography, which included work that led to the Lytro camera, whose photographs could be refocused after they were captured.. Dr. Horowitz's current research interests are quite broad and span using EE and CS analysis methods to problems in neuro and molecular biology to creating new agile design methodologies for analog and digital VLSI circuits. He remains interested in learning new things, and building interdisciplinary teams. -
Hadi Hosseini
Associate Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsOur lab’s research portfolio crosses multiple disciplines including computational neuropsychiatry, cognitive neuroscience, multimodal neuroimaging and neurocognitive rehabilitation. Our computational neuropsychiatry research mainly involves investigating alterations in the organization of connectome in various neurodevelopmental and neurocognitive disorders using state of the art neuroimaging techniques (fMRI, sMRI, DWI, functional NIRS) combined with novel computational methods (graph theoretical and multivariate pattern analyses).
The ultimate goal of our research is to translate the findings from computational neuropsychiatry research toward developing personalized interventions. We have been developing personalized interventions that integrate computerized cognitive rehabilitation, real-time functional brain imaging and neurofeedback, as well as virtual reality (VR) tailored toward targeted rehabilitation of the affected brain networks in patients with neurocognitive disorders. -
Kristene Hossepian, Psy.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kristene Hossepian is a licensed clinical psychologist with expertise in anxiety, depression, eating disorders, parent management training, and stress. During her doctorate training at the PGSP-Stanford Psy.D. Consortium she received extensive training in a number of evidence-based treatment approaches for children and adolescents, such as Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, and Acceptance and Commitment Therapy. She completed her pre-doctoral internship at Lucile Packard Children’s Hospital/Children’s Health Council where she worked with youth struggling with severe eating disorders, chronic medical conditions, trauma, depression, and anxiety. After receiving her doctorate in 2020, Dr. Hossepian completed her postdoctoral fellowship at the Stanford University School of Medicine, where she continued to receive training in evidence-based treatments for youth with a variety of presenting problems at the inpatient and outpatient level.
Currently, Dr. Hossepian is a Clinical Assistant Professor within the Division of Child and Adolescent Psychiatry at the Stanford University School of Medicine. She works alongside Dr. Mary Sanders and Dr. Jennifer Derenne at the Comprehensive Care Program serving children and adolescents who are medically compromised due to complications with their eating disorders. Additionally, Dr. Hossepian works within Dr. Victoria Cosgrove’s Stress, Resilience, Emotion, and Mood (StREam) Laboratory to identify the ways that psychobiological stress responsivity is implicated in the emergence and propagation of affective symptomatology. Dr. Hossepian is interested in exploring the physiological mechanisms underlying mood disorders and eating disorders as well as providing children and adolescents with novel emotion regulation strategies. -
David Hovsepian, MD
Current Research and Scholarly InterestsI am interested in the diagnosis and treatment of vascular malformations in both children and adults; all aspects of gynecological intervention, especially uterine fibroid embolization; and in the developing sciences of quality, safety, and radiology informatics.
-
Roger Howe
William E. Ayer Professor of Electrical Engineering, Emeritus
BioDesign and fabrication of sensors and actuators using micro and nanotechnologies, with applications to information processing and energy conversion.
-
Brooke Howitt
Irene Adler Professor
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Caroline Hoxby
Scott and Donya Bommer Professor in the School of Humanities and Sciences, Senior Fellow at the Hoover Institution and at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics at the GSB
BioCaroline Hoxby is the Scott and Donya Bommer Professor of Economics at Stanford University, a Senior Fellow of the Hoover Institution, and the Director of the Economics of Education Program at the National Bureau of Economic Research. Before moving to Stanford, she was the Allie S. Fried Professor of Economics at Harvard University. A public and labor economist, Hoxby is one of the world's leading scholars in the Economics of Education. She is especially well known for promoting scientific methods in education research. She was the Principal Investigator of the Expanding College Opportunities project, which had dramatic effects on low-income, high achievers' college-going. For this project, recently received The Smithsonian Institution's Ingenuity Award. Some of the other research for which she is best known includes explaining the rising cost of higher education, the effects of school choice and charter schools on student achievement, and the effects of teacher unionization. She also writes on public school finance, peer effects, and how education affects economic growth. Her recent series of Tanner Lectures on Human Values (Berkeley) focuses on neuroscience and the cognitive skills of adolescents. She is a past Vice-President of the American Economic Association and the current Vice-President of the Western Economic Association International. Hoxby is a Fellow of the American Academy of Arts and Sciences, the British Academy, and the American Academy of Sciences and Letters. She is an award-winning instructor and advisor and is a Bass University Fellow in Undergraduate Education at Stanford University. Hoxby has a Ph.D. from MIT, studied at Oxford as a Rhodes Scholar, and obtained her baccalaureate degree summa cum laude from Harvard University.
-
Alison Hoyt
Assistant Professor of Earth System Science
BioAlison Hoyt is an Assistant Professor of Earth System Science at Stanford. Her work focuses on understanding how biogeochemical cycles respond to human impacts, with a particular focus on the most vulnerable and least understood carbon stocks in the tropics and the Arctic. For more information, please visit her group website here: https://carboncycle.stanford.edu/
-
Dimitre Hristov
Associate Professor of Radiation Oncology (Radiation Physics), Emeritus
Current Research and Scholarly InterestsDevelopment and integration of X-ray, MRI and US imaging technologies for radiation therapy guidance; Design of synergistic approaches to radiation therapy delivery; Treatment planning optimization and modeling.
-
Solomon Hsiang
Professor of Environmental Social Sciences and Senior Fellow at the Stanford Institute for Economic Policy Research
Current Research and Scholarly InterestsEnvironmental Policy, Economics, Data Science, Intl Governance, Climate
-
Aaron Hsueh
Professor of Obstetrics and Gynecology (Reproductive and Stem Cell Biology), Emeritus
Current Research and Scholarly InterestsHormonal regulation of ovarian function; gonadotropin receptors and related genes, bioinformatic ananlyses of polypeptide hormones and receptors, follicle recruitment and GDF-9; analysis of oocyte and ovarian-expressed genes.
-
Yang Hu, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
KC Huang
LeRa Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsHow do cells determine their shape and grow?
How do molecules inside cells get to the right place at the right time?
Our group tries to answer these questions using a systems biology approach, in which we integrate interacting networks of protein and lipids with the physical forces determined by the spatial geometry of the cell. We use theoretical and computational techniques to make predictions that we can verify experimentally using synthetic, chemical, or genetic perturbations. -
Leslie Huang
Sr. Industrial Contracts Officer, Office of Technology Licensing (OTL)
BioLeslie is an Industrial Contracts Officer in Stanford's Office of Technology Licensing.
Prior to joining Stanford, Leslie was a process engineer at Applied Materials and an in-house attorney at various Bay Area technology companies focusing on intellectual property and commercial transactions. She earned a B.A. in History and a B.S. in Materials Science Engineering with an Electronic Materials Specialization from UCLA and a J.D. with a High Tech Law Certificate (Intellectual Property Specialization) from Santa Clara University School of Law. She is admitted to practice law in the State of California. -
Ngan F. Huang
Associate Professor of Cardiothoracic Surgery (Cardiothoracic Surgery Research) and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsDr. Huang's laboratory aims to understand the chemical and mechanical interactions between extracellular matrix (ECM) proteins and pluripotent stem cells that regulate vascular and myogenic differentiation. The fundamental insights of cell-matrix interactions are applied towards stem cell-based therapies with respect to improving cell survival and regenerative capacity, as well as engineered vascularized tissues for therapeutic transplantation.
-
Possu Huang
Assistant Professor of Bioengineering
Current Research and Scholarly InterestsProtein design: molecular engineering, method development and novel therapeutics
-
Ting-Ting Huang
Associate Professor (Research) of Neurology (Adult Neurology), Emerita
Current Research and Scholarly InterestsWe study the role of oxygen free radicals in oxidative tissue damage and degeneration. Our research tools include transgenic and knockout mice and tissue culture cells for in vitro gene expression.
-
Andrew D. Huberman
Associate Professor of Neurobiology and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAndrew Huberman is a tenured associate professor of neurobiology and of ophthalmology at Stanford University School of Medicine, where he directs the Huberman Lab. After earning his B.A. from the University of California, Santa Barbara and completing M.A. and Ph.D. degrees in neuroscience at UC Berkeley and UC Davis, he conducted post-doctoral work at Stanford.
-
Adrian Hugenmatter
Senior Research Scientist-Basic Life, Sarafan ChEM-H
BioDr. Adrian Hugenmatter joined ChEM-H as Director of Protein Engineering in 2021. In his role, Dr. Hugenmatter heads the Protein Engineering Laboratory at the Nucleus and is responsible for the development of therapeutic proteins at the Innovative Medicines Accelerator (IMA). Dr. Hugenmatter obtained his PhD in the laboratory of Prof. Donald Hilvert at the Swiss Federal Institute of Technology in Zurich (ETH Zurich, Switzerland), where he gained initial experience in the fields of enzymology, antibody engineering and directed evolution. Fascinated by protein engineering, he moved to the laboratory of Prof. Dan Tawfik at the Weizmann Institute of Science (Israel), where he studied molecular evolution and its application in protein design. Dr. Hugenmatter then worked for more than a decade as a researcher and team leader at Roche. During this time, he was involved in the development and optimization of several antibody lead candidates for therapeutic applications in neuroscience and oncology.
-
John Huguenard
Professor of Neurology and Neurological Sciences (Neurology Research), of Neurosurgery (Adult Neurosurgery) and, by courtesy, of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe are interested in the neuronal mechanisms that underlie synchronous oscillatory activity in the thalamus, cortex and the massively interconnected thalamocortical system. Such oscillations are related to cognitive processes, normal sleep activities and certain forms of epilepsy. Our approach is an analysis of the discrete components (cells, synapses, microcircuits) that make up thalamic and cortical circuits, and reconstitution of components into in silico computational networks.
-
Keith Humphreys
Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.
-
Paul S Humphries
Alliance Director, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAlliance Director, Stanford Innovative Medicines Accelerator (IMA)
-
Sohail Z Husain
Chambers-Okamura Endowed Professor of Pediatric Gastroenterology
Current Research and Scholarly InterestsMy research delves into three broad areas of the exocrine pancreas: (1) The crucial signaling pathways that initiate and transduce pancreatitis; (2) the factors that turn on pancreatic regeneration and recovery after pancreatic injury; and (3) the mechanisms underlying drug-induced pancreatitis.
-
Ruth Huttenhain
Assistant Professor of Molecular and Cellular Physiology
Current Research and Scholarly InterestsMy group deciphers how G protein-coupled receptors decode extracellular cues into dynamic and context-specific cellular signaling networks to elicit diverse physiologic responses. We exploit quantitative proteomics to capture the spatiotemporal organization of signaling networks combined with functional genomics to study their impact on physiology.
-
Gloria Hwang, MD
Current Research and Scholarly InterestsInterventional oncology, pancreatic interventions, image-guided gene therapy.
-
Jackelyn Hwang
Associate Professor of Sociology
BioJackelyn Hwang is an Associate Professor in the Department of Sociology and Director of the Changing Cities Research Lab. Jackelyn’s main research interests are in the fields of urban sociology, race and ethnicity, immigration, and inequality. In particular, her research uses innovative data, measures, and methods to answer: how do neighborhood-level dynamics that are typically racialized drive changes in US residential segregation? Her projects focus on how residential sorting mechanisms shape how gentrification unfolds over time and space, the consequences of gentrification on residential displacement, and developing data and measurement infrastructures for improving measures of gentrification, including developing automated methods using computer vision to measure visible neighborhood conditions and their changes over time from Google Street View imagery. By improving our understanding of urban change and segregation, her work aims to advance policy solutions that promote racial equity as cities change.
Jackelyn received her B.A.S. in Sociology and Mathematics from Stanford University and her Ph.D. in Sociology and Social Policy from Harvard University. After completing her Ph.D., she was a Postdoctoral Research Fellow in the Office of Population Research at Princeton University. Her research has been supported by the American Sociological Association, the Joint Center for Housing Studies, the National Science Foundation, among others. Her work has appeared in the American Journal of Sociology, American Sociological Review, City & Community, Demography, Social Forces, Sociological Methods and Research, Sociological Methodology, and Urban Affairs Review, and other academic journals. -
Joo Ha Hwang, MD, PhD
Fortinet Founders School of Medicine Professor and Professor, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
Patrick Hynes
Senior Manager of Research Communities, Institute for Human-Centered Artificial Intelligence (HAI)
Current Role at StanfordSenior Manager of Research Communities at Stanford HAI
-
Gianluca Iaccarino
Robert Bosch Chair of the Department of Mechanical Engineering and Joseph L. and Roberta M. Rodgers Professor
Current Research and Scholarly InterestsComputing and data for energy, health and engineering
Challenges in energy sciences, green technology, transportation, and in general, engineering design and prototyping are routinely tackled using numerical simulations and physical testing. Computations barely feasible two decades ago on the largest available supercomputers, have now become routine using turnkey commercial software running on a laptop. Demands on the analysis of new engineering systems are becoming more complex and multidisciplinary in nature, but exascale-ready computers are on the horizon. What will be the next frontier? Can we channel this enormous power into an increased ability to simulate and, ultimately, to predict, design and control? In my opinion two roadblocks loom ahead: the development of credible models for increasingly complex multi-disciplinary engineering applications and the design of algorithms and computational strategies to cope with real-world uncertainty.
My research objective is to pursue concerted innovations in physical modeling, numerical analysis, data fusion, probabilistic methods, optimization and scientific computing to fundamentally change our present approach to engineering simulations relevant to broad areas of fluid mechanics, transport phenomena and energy systems. The key realization is that computational engineering has largely ignored natural variability, lack of knowledge and randomness, targeting an idealized deterministic world. Embracing stochastic scientific computing and data/algorithms fusion will enable us to minimize the impact of uncertainties by designing control and optimization strategies that are robust and adaptive. This goal can only be accomplished by developing innovative computational algorithms and new, physics-based models that explicitly represent the effect of limited knowledge on the quantity of interest.
Multidisciplinary Teaching
I consider the classical boundaries between disciplines outdated and counterproductive in seeking innovative solutions to real-world problems. The design of wind turbines, biomedical devices, jet engines, electronic units, and almost every other engineering system requires the analysis of their flow, thermal, and structural characteristics to ensure optimal performance and safety. The continuing growth of computer power and the emergence of general-purpose engineering software has fostered the use of computational analysis as a complement to experimental testing in multiphysics settings. Virtual prototyping is a staple of modern engineering practice! I have designed a new undergraduate course as an introduction to Computational Engineering, covering theory and practice across multidisciplanary applications. The emphasis is on geometry modeling, mesh generation, solution strategy and post-processing for diverse applications. Using classical flow/thermal/structural problems, the course develops the essential concepts of Verification and Validation for engineering simulations, providing the basis for assessing the accuracy of the results. -
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Current Research and Scholarly InterestsCurrent research projects include:
1) PET/MRI and PET/CT for Early Cancer Detection
2) Targeted Radionuclide Therapy
3) Clinical Translation of Novel PET Radiopharmaceuticals; -
Matthias Ihme
Professor of Mechanical Engineering, of Photon Science and, by courtesy, of Energy Science and Engineering
BioLarge-eddy simulation and modeling of turbulent reacting flows, non-premixed flame, aeroacoustics and combustion generated noise, turbulence and fluid dynamics, numerical methods and high-order schemes.
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Daniel Imler
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.
-
John P.A. Ioannidis
George E. and Lucy Becker Professor of Medicine, Professor of Epidemiology and Population Health and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Tauhid (Md Tauhidul) Islam
Assistant Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy research focuses on developing computationally efficient and clinically reliable AI methods for biomedical imaging and high-dimensional molecular data, with an emphasis on cancer and neurological disease. The Islam Lab designs novel representations and learning frameworks that improve deep learning performance in data-constrained biomedical settings, including methods that transform tabular omics data into spatially meaningful representations.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence (AI) techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multiomic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include data science/AI-powered prediction modeling of survival, treatment response, cancer recurrence, and metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her goal is to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Robert K. Jackler, MD
Edward C. and Amy H. Sewall Professor, Emeritus
Current Research and Scholarly InterestsSince the early 2000s, study of tobacco industry marketing has become my primary field of research. Motivated by the lack of a comprehensive and well-organized compendium of tobacco advertisements, and the relative paucity of scholarly research analyzing the marketing practices of the industry, I chose to focus my research on advertising. The overarching purpose of my research has been to reveal the behavior of the tobacco industry in recruiting and retaining its consumers with the goal of infor
-
Matthew O. Jackson
Eberle Professor of Economics and Senior Fellow at the Stanford Institute for Economic Policy Research
Biohttp://www.stanford.edu/~jacksonm/bio.html
-
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Christine Jacobs-Wagner
Dennis Cunningham Professor, Professor of Biology and of Microbiology and Immunology
BioChristine Jacobs-Wagner is a Dennis Cunningham Professor in the Department of Biology and the ChEM-H Institute at Stanford University. She is interested in understanding the fundamental mechanisms and principles by which cells, and, in particular, bacterial cells, are able to multiple. She received her PhD in Biochemistry in 1996 from the University of Liège, Belgium where she unraveled a molecular mechanism by which some bacterial pathogens sense and respond to antibiotics attack to achieve resistance. For this work, she received multiple awards including the 1997 GE & Science Prize for Young Life Scientists. During her postdoctoral work at Stanford Medical School, she demonstrated that bacteria can localize regulatory proteins to specific intracellular regions to control signal transduction and the cell cycle, uncovering a new, unsuspected level of bacterial regulation.
She started her own lab at Yale University in 2001. Over the years, her group made major contributions in the emerging field of bacterial cell biology and provided key molecular insights into the temporal and spatial mechanisms involved in cell morphogenesis, cell polarization, chromosome segregation and cell cycle control. For her distinguished work, she received the Pew Scholars award from the Pew Charitable Trust, the Woman in Cell Biology Junior award from the American Society of Cell Biology and the Eli Lilly award from the American Society of Microbiology. She held the Maxine F. Singer and William H. Fleming professor chairs at Yale. She was elected to the Connecticut academy of Science, the American Academy of Microbiology and the National Academy of Sciences. She has been an investigator of the Howard Hughes Medical Institute since 2008.
Her lab moved to Stanford in 2019. Current research examines the general principles and spatiotemporal mechanisms by which bacterial cells replicate, using Caulobacter crescentus and Escherichia coli as models. Recently, the Jacobs-Wagner lab expanded their interests to the Lyme disease agent Borrelia burgdorferi, revealing unsuspected ways by which this pathogen grows and causes disease -
Amy Jacobson
Director of Microbiome Therapies, Microbiome Therapies Initiative (MITI)
Current Role at StanfordSenior Scientific Program Manager, Sarafan ChEM-H and Stanford Innovative Medicines Accelerator
-
Prasanna Jagannathan
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsWe study innate immunity and immune regulation of Plasmodium Falciparum malaria in children and pregnant women. Our work focuses on understanding how malaria shapes the immune state in individuals following repeated exposure. We are also testing novel interventions to enhance protective immunity against malaria in children via large, randomized controlled trials. Our work in malaria has been based in Eastern Uganda, where malaria transmission is among the highest in the world.
-
Abhi Jain
Clinical Assistant Professor, Radiology
BioDr. Jain is a neuroradiologist and a Certified Imaging Informatics Professional (CIIP) whose academic work bridges day-to-day neuroradiology practice with imaging informatics and clinically grounded artificial intelligence (AI).
His clinical research interests include quantitative imaging and radiomics in cerebrovascular disease, with particular emphasis on intracerebral hemorrhage (ICH), and imaging biomarkers in the aging brain and neurodegeneration, including limbic-predominant age-related TDP-43 encephalopathy (LATE).
His AI/informatics and quality-improvement interests include large language models (LLMs) for radiology reporting support and clinical decision support, with an emphasis on real-world evaluation and workflow integration.
His education interests focus on modern, technology-enabled neuroradiology teaching, including tailored language models and extended reality (XR; augmented/virtual/mixed reality) approaches to strengthen trainee learning. -
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Doug James
LeRa Professor and Professor, by courtesy, of Music
Current Research and Scholarly InterestsComputer graphics & animation, physics-based sound synthesis, computational physics, haptics, reduced-order modeling
-
Michelle L. James
Associate Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology and Neurological Sciences (Neurology Research)
Current Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Ted Jardetzky
Professor of Structural Biology
Current Research and Scholarly InterestsThe Jardetzky laboratory is studying the structures and mechanisms of macromolecular complexes important in viral pathogenesis, allergic hypersensitivities and the regulation of cellular growth and differentiation, with an interest in uncovering novel conceptual approaches to intervening in disease processes. Ongoing research projects include studies of paramyxovirus and herpesvirus entry mechanisms, IgE-receptor structure and function and TGF-beta ligand signaling pathways.
-
Daniel Jarosz
Senior Associate Dean, Basic Science, Professor of Chemical and Systems Biology and of Developmental Biology
Current Research and Scholarly InterestsMy laboratory studies conformational switches in evolution, disease, and development. We focus on how molecular chaperones, proteins that help other biomolecules to fold, affect the phenotypic output of genetic variation. To do so we combine classical biochemistry and genetics with systems-level approaches. Ultimately we seek to understand how homeostatic mechanisms influence the acquisition of biological novelty and identify means of manipulating them for therapeutic and biosynthetic benefit.
-
Alireza Javadian Sabet
Affiliate, Stanford Digital Economy Lab (S-DEL)
BioAlireza Javadian Sabet is a Postdoctoral Scholar at the University of Chicago Knowledge Lab and a Digital Fellow at Stanford Digital Economy Lab. He earned a PhD in Information Science from the Resilient Economy Lab at the University of Pittsburgh, where his research focused on mapping career adaptability and understanding how skills and experience translate into changing sets of opportunities over time. He also holds a master’s degree in Computer Science and Engineering from Politecnico di Milano (PoliMi) and previously served as a research fellow at the Data Science Lab and the DEpendable Evolvable Pervasive Software Engineering group. His work has been discussed in policy and business outlets, including The Economist and the American Enterprise Institute.
Alireza studies how transformative AI reshapes labor markets and innovation systems, developing models and measures from large-scale datasets that link technological capabilities to changes in skills, mobility, and knowledge production. His work combines text and trajectory data to track skill formation in education, quantify how career opportunities expand or concentrate over time, and connect these dynamics to the movement of talent across organizations and borders. He is motivated by the broader challenge of assessing and predicting technology outcomes, including how advances diffuse through tasks and institutions, and how choices around funding, training, and governance influence who benefits from technological change. -
R Brooke Jeffrey
Professor of Radiology (Body Imaging), Emeritus
Current Research and Scholarly InterestsPancreatic MDCT
Thyroid ultrasound/biopsy
Virtual Colonoscopy
Imaging of appendicitis
Hepatic MDCT
Capsule ultrasound (wireless) of GI tract -
Stefanie S. Jeffrey, MD
John and Marva Warnock Professor, Emerita
Current Research and Scholarly InterestsDr. Jeffrey led the multidisciplinary team from the Schools of Medicine, Engineering, and Genome Technology Center that invented the MagSweeper, an automated device that immunomagnetically captures live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis or culture. Her lab also works on microfluidic technologies for tumor cell capture, characterization, and growth - with the goal of defining individual patient response to newer biologically-based cancer therapies.
-
Livnat Jerby
Assistant Professor of Genetics
Current Research and Scholarly InterestsCombining and advancing functional genomics, cell engineering, synthetic biology, AI, and basic immunology to uncover, decode, rewire, and develop mechanisms to selectively eliminate and reprogram disease-driving cells as a foundation for disease treatment and prevention.
